| CASE REPORT |
|
| Year : 2015 | Volume
: 4
| Issue : 1 | Page : 135-136 |
|
|
Infantile hemangioma in a V2 distribution: Treatment with nadolol
Mariah Giberson, Robert Hayes
Dalhousie Medicine New Brunswick, Saint John, New Brunswick, Canada
Correspondence Address:
Mariah Giberson
Dalhousie Medicine New Brunswick, 100 Tucker Park Road, PO Box 5050, Saint John, New Brunswick, E2L4L5
Canada
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2249-4863.152272
|
|
|
Infantile hemangiomas are common benign tumours of infancy affecting up to 10% of children. They are typically not present at birth but undergo a rapid proliferation stage and then plateau in growth before resolving spontaneously. Recently, beta-blockers have been favoured over systemic corticosteroids for treatment of disfiguring or life-threatening infantile hemangiomas. We present a case of an 11-week-old female with a 7 week history of an evolving hemangioma along a facial V2 distribution. Physical exam revealed a well-defined bright red plaque over the right zygoma and lower eyelid. MRI, echocardiograph, and liver ultrasound were normal. Patient was treated with nadolol and had a rapid and substantial regression of the hemangioma. Nadolol is an effective treatment option for disfiguring facial infantile hemangioma. The use of beta-blockers as treatment offers clues into the pathogenesis of infantile hemangioma, which is not yet completely understood |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
